Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,511 announcements in the last 12 months · page 90 of 106
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Foghorn Therapeutics Inc. (FHTX) | Q4 FY2025 | $9.2M | 223.8% | $-21.7M | -0.34 | — | 8-K |
| 2026-01-12 | EDAP TMS SA (FOCL) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-01-12 | Fulcrum Therapeutics, Inc. (FULC) | Q4 FY2025 | — | — | $-20.3M | -0.31 | — | 8-K |
| 2026-01-12 | Guardant Health, Inc. (GH) | Q4 FY2025 | $281.3M | 39.4% | $-128.5M | -1.00 | — | 8-K |
| 2026-01-12 | Hyperfine, Inc. (HYPR) | Q4 FY2025 | $5.3M | 128.0% | $-5.9M | -0.06 | — | 8-K |
| 2026-01-12 | Inogen Inc (INGN) | Q4 FY2025 | $68.6M | 3.4% | $-7.1M | -0.26 | — | 8-K |
| 2026-01-12 | IRIDEX CORP (IRIX) | Q4 FY2026 | $14.7M | — | $-184,000 | -0.01 | — | 8-K |
| 2026-01-12 | ORTHOPEDIATRICS CORP (KIDS) | Q4 FY2025 | $61.6M | 17.0% | $-10.1M | -0.43 | — | 8-K |
| 2026-01-12 | Moderna, Inc. (MRNA) | Q4 FY2025 | $678.0M | -29.8% | $-826.0M | -2.11 | — | 8-K |
| 2026-01-12 | MAXCYTE, INC. (MXCT) | Q4 FY2025 | $4.8M | -20.9% | $-9.6M | -0.09 | — | 8-K |
| 2026-01-12 | NOODLES & Co (NDLS) | Q4 FY2025 | $122.8M | 0.8% | $-6.8M | — | — | 8-K |
| 2026-01-12 | Neostellar Capital Corp. (NSLR) | Q4 FY2025 | — | — | $-20.1M | -0.67 | -35521.1% | 8-K |
| 2026-01-12 | Natera, Inc. (NTRA) | Q4 FY2025 | $665.5M | 39.8% | $47.3M | 0.34 | — | 8-K |
| 2026-01-12 | REGENERON PHARMACEUTICALS, INC. (REGN) | Q4 FY2025 | $3.88B | 2.5% | $844.6M | 7.84 | -2.9% | 8-K |
| 2026-01-12 | RxSight, Inc. (RXST) | Q4 FY2025 | $32.6M | -18.9% | $-9.2M | -0.22 | — | 8-K |
| 2026-01-12 | Syndax Pharmaceuticals Inc (SNDX) | Q4 FY2025 | $68.7M | 794.9% | $-68.0M | -0.78 | — | 8-K |
| 2026-01-12 | ONE Group Hospitality, Inc. (STKS) | Q4 FY2025 | $207.0M | -6.7% | $-6.4M | -0.20 | -490.7% | 8-K |
| 2026-01-12 | Savers Value Village, Inc. (SVV) | Q4 FY2025 | $464.7M | — | $22.4M | 0.14 | — | 8-K |
| 2026-01-12 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Q4 FY2025 | $4.71B | 11.4% | $480.0M | 0.41 | — | 8-K |
| 2026-01-12 | Terra Property Trust, Inc. (TPTS) | Q4 FY2025 | $-65,227 | — | $-10.6M | -0.44 | — | 8-K |
| 2026-01-12 | US Foods Holding Corp. (USFD) | Q4 FY2025 | $9.80B | 3.3% | $184.0M | 0.82 | 192.1% | 8-K |
| 2026-01-12 | Utz Brands, Inc. (UTZ) | Q4 FY2025 | $342.2M | 0.4% | $-2.5M | -0.03 | -207.7% | 8-K |
| 2026-01-12 | Venture Global, Inc. (VG) | Q4 FY2025 | $4.45B | 191.7% | $1.19B | 0.45 | 19.6% | 8-K |
| 2026-01-12 | Wave Life Sciences, Inc. (WVE) | Q4 FY2025 | — | — | $-53.2M | -0.30 | -262.9% | 8-K |
| 2026-01-12 | EXAGEN INC. (XGN) | Q4 FY2025 | $16.6M | 21.8% | $-4.7M | -0.20 | — | 8-K |
| 2026-01-09 | ALUMIS INC. (ALMS) | Q4 FY2025 | $1.9M | — | $-92.9M | -0.89 | — | 8-K |
| 2026-01-09 | Boot Barn Holdings, Inc. (BOOT) | Q3 FY2026 | $705.6M | 16.0% | $85.8M | 2.79 | 14.8% | 8-K |
| 2026-01-09 | Evolus, Inc. (EOLS) | Q4 FY2025 | $90.3M | 14.4% | $130,000 | 0.00 | — | 8-K |
| 2026-01-09 | HURCO COMPANIES INC (HURC) | Q4 FY2025 | $45.5M | -15.3% | $-3.0M | -0.47 | — | 8-K |
| 2026-01-09 | Immunocore Holdings plc (IMCR) | Q4 FY2025 | $104.5M | 24.3% | $-30.1M | -0.59 | — | 8-K |
| 2026-01-08 | AMARIN CORP PLC\UK (AMRN) | Q4 FY2025 | $49.2M | -21.0% | $-1.2M | -0.00 | — | 8-K |
| 2026-01-08 | Anika Therapeutics, Inc. (ANIK) | Q4 FY2025 | $30.6M | 0.0% | $292,000 | 0.02 | — | 8-K |
| 2026-01-08 | Axil Brands, Inc. (AXIL) | Q2 FY2026 | $8.1M | 5.2% | $704,883 | 0.09 | 12.5% | 8-K |
| 2026-01-08 | ACUITY INC. (DE) (AYI) | Q1 FY2026 | $1.14B | 20.2% | $120.5M | 3.82 | 14.0% | 8-K |
| 2026-01-08 | CorMedix Inc. (CRMD) | Q4 FY2025 | $128.6M | 312.1% | $14.0M | — | — | 8-K |
| 2026-01-08 | EDUCATIONAL DEVELOPMENT CORP (EDUC) | Q3 FY2026 | $7.0M | -36.6% | $7.8M | 0.91 | — | 8-K |
| 2026-01-08 | GREENBRIER COMPANIES INC (GBX) | Q1 FY2026 | $706.1M | -19.4% | $36.4M | 1.14 | -33.7% | 8-K |
| 2026-01-08 | GOLDMAN SACHS GROUP INC (GS) | Q4 FY2025 | $13.45B | -3.0% | $4.62B | 14.76 | 17.9% | 8-K |
| 2026-01-08 | HELEN OF TROY LTD (HELE) | Q3 FY2026 | $512.8M | -3.4% | $-84.1M | -3.65 | -268.2% | 8-K |
| 2026-01-08 | IMMUCELL CORP /DE/ (ICCC) | Q4 FY2025 | $7.6M | -1.6% | $-2.8M | -0.31 | -646.9% | 8-K |
| 2026-01-08 | Invivyd, Inc. (IVVD) | Q4 FY2025 | $17.2M | 24.5% | $-11.1M | -0.04 | — | 8-K |
| 2026-01-08 | LINDSAY CORP (LNN) | Q1 FY2025 | $150.7M | -6.1% | $16.5M | 1.54 | -1.9% | 8-K |
| 2026-01-08 | MSC INCOME FUND, INC. (MSIF) | Q4 FY2025 | — | — | $30.0M | 0.64 | 25.8% | 8-K |
| 2026-01-08 | NEOGEN CORP (NEOG) | Q2 FY2026 | $224.7M | -2.8% | $-15.9M | -0.07 | — | 8-K |
| 2026-01-08 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) | Q1 FY2026 | $23.3M | 9.2% | $237,819 | 0.03 | -50.0% | 8-K |
| 2026-01-08 | PURE CYCLE CORP (PCYO) | Q1 FY2026 | $9.1M | 58.8% | $4.6M | 0.19 | 18.8% | 8-K |
| 2026-01-08 | Postal Realty Trust, Inc. (PSTL) | Q4 FY2025 | $26.0M | 21.7% | $4.6M | 0.18 | -8.1% | 8-K |
| 2026-01-08 | RPM INTERNATIONAL INC/DE/ (RPM) | Q2 FY2026 | $1.91B | 3.5% | $161.2M | 1.26 | -11.3% | 8-K |
| 2026-01-08 | Simulations Plus, Inc. (SLP) | Q1 FY2026 | $18.4M | -2.7% | $676,000 | 0.03 | 200.0% | 8-K |
| 2026-01-08 | Simply Good Foods Co (SMPL) | Q1 FY2026 | $340.2M | -0.3% | $25.3M | 0.26 | -31.6% | 8-K |
| 2026-01-08 | TD SYNNEX CORP (SNX) | Q4 FY2025 | $17.38B | 9.7% | $248.4M | 3.07 | 33.2% | 8-K |
| 2026-01-08 | SPRUCE BIOSCIENCES, INC. (SPRB) | Q4 FY2025 | — | — | $-14.6M | -11.35 | — | 8-K |
| 2026-01-08 | Tilray Brands, Inc. (TLRY) | Q2 FY2026 | $217.5M | 3.1% | $-44.9M | -0.41 | — | 8-K |
| 2026-01-08 | Entrada Therapeutics, Inc. (TRDA) | Q4 FY2025 | $1.3M | -96.5% | $-39.2M | -0.94 | -3697.0% | 8-K |
| 2026-01-08 | WD 40 CO (WDFC) | Q1 FY2026 | $154.4M | 0.6% | $17.5M | 1.28 | -7.9% | 8-K |
| 2026-01-08 | Xilio Therapeutics, Inc. (XLO) | Q4 FY2025 | $13.7M | 693.9% | $10.4M | — | — | 8-K |
| 2026-01-07 | AbbVie Inc. (ABBV) | Q4 FY2025 | $16.62B | 10.0% | $1.82B | 1.02 | — | 8-K |
| 2026-01-07 | BTCS Inc. (BTCS) | Q4 FY2025 | $7.1M | 205.3% | $-85.6M | — | — | 8-K |
| 2026-01-07 | CAL-MAINE FOODS INC (CALM) | Q2 FY2026 | $769.5M | -19.4% | $102.8M | 2.13 | -52.3% | 8-K |
| 2026-01-07 | CHS INC (CHSCP) | Q1 FY2026 | $8.86B | -4.6% | $260.5M | — | — | 8-K |
| 2026-01-07 | CION Investment Corp (CION) | Q4 FY2025 | — | — | $-41.1M | -0.80 | -877.5% | 8-K |
| 2026-01-07 | EyePoint, Inc. (EYPT) | Q4 FY2025 | $620,000 | -94.6% | $-67.6M | — | — | 8-K |
| 2026-01-07 | FRANKLIN COVEY CO (FC) | Q1 FY2026 | $64.0M | -7.3% | $-3.3M | -0.27 | -400.0% | 8-K |
| 2026-01-07 | GLOBUS MEDICAL INC (GMED) | Q4 FY2025 | $826.4M | 25.7% | $140.6M | 1.03 | 442.6% | 8-K |
| 2026-01-07 | KURA SUSHI USA, INC. (KRUS) | Q1 FY2026 | $73.5M | 14.0% | $-3.1M | -0.25 | — | 8-K |
| 2026-01-07 | LENZ Therapeutics, Inc. (LENZ) | Q4 FY2025 | $1.6M | — | $-35.9M | -1.16 | — | 8-K |
| 2026-01-07 | Mobileye Global Inc. (MBLY) | Q4 FY2025 | $446.0M | -9.0% | $-127.0M | -0.16 | — | 8-K |
| 2026-01-07 | MSC INDUSTRIAL DIRECT CO INC (MSM) | Q1 FY2026 | $965.7M | 4.0% | $51.8M | 0.93 | 12.0% | 8-K |
| 2026-01-07 | Blue Owl Capital Corp (OBDC) | Q4 FY2025 | — | — | $119.1M | 0.23 | -40.9% | 8-K |
| 2026-01-07 | Blue Owl Technology Finance Corp. (OTF) | Q4 FY2025 | $720,000 | — | $205.8M | 0.44 | — | 8-K |
| 2026-01-07 | Phathom Pharmaceuticals, Inc. (PHAT) | Q4 FY2025 | $57.6M | 94.1% | $-21.1M | -0.29 | — | 8-K |
| 2026-01-07 | PSQ Holdings, Inc. (PSQH) | Q4 FY2025 | $7.3M | 109.0% | $-11.8M | -0.25 | — | 8-K |
| 2026-01-07 | RICHARDSON ELECTRONICS, LTD. (RELL) | Q2 FY2026 | $52.3M | 5.7% | $-121,000 | — | — | 8-K |
| 2026-01-07 | RESOURCES CONNECTION, INC. (RGP) | Q2 FY2026 | $117.7M | -19.2% | $-12.7M | -0.38 | — | 8-K |
| 2026-01-07 | SARATOGA INVESTMENT CORP. (SAR) | Q3 FY2026 | — | — | $12.0M | 0.74 | 15.6% | 8-K |
| 2026-01-07 | CONSTELLATION BRANDS, INC. (STZ) | Q3 FY2026 | $2.22B | -9.8% | $502.8M | — | — | 8-K |
| 2026-01-06 | ANGIODYNAMICS INC (ANGO) | Q2 FY2026 | $79.4M | 9.0% | $-6.3M | -0.15 | — | 8-K |
| 2026-01-06 | Edible Garden AG Inc (EDBL) | Q4 FY2025 | $4.1M | 6.6% | $3.9M | — | — | 8-K |
| 2026-01-05 | AmpliTech Group, Inc. (AMPG) | Q4 FY2025 | $4.5M | 141.6% | $-3.2M | -0.14 | — | 8-K |
| 2026-01-05 | MICROCHIP TECHNOLOGY INC (MCHP) | Q3 FY2026 | $1.19B | 15.6% | $62.7M | 0.06 | — | 8-K |
| 2026-01-05 | WEC ENERGY GROUP, INC. (WEC) | Q4 FY2025 | $2.54B | 11.1% | $316.8M | 0.97 | -32.3% | 8-K |
| 2026-01-02 | Apollo Global Management, Inc. (APO) | Q4 FY2025 | $9.86B | 86.7% | $684.0M | 1.14 | -50.3% | 8-K |
| 2026-01-02 | NEXTERA ENERGY INC (NEE) | Q4 FY2025 | $6.10B | 15.1% | $1.53B | 0.73 | 25.9% | 8-K |
| 2026-01-02 | Tesla, Inc. (TSLA) | Q4 FY2025 | $24.90B | -3.1% | $840.0M | 0.24 | -60.7% | 8-K |
| 2025-12-31reported in filing | TAYLOR DEVICES, INC. (TAYD) | Q2 FY2026 | $11.6M | 35.7% | $2.0M | — | — | 8-K |
| 2025-12-29reported in filing | CEMTREX INC (CETX) | Q4 FY2025 | $18.5M | 2.2% | $-3.2M | — | — | 8-K |
| 2025-12-29 | Compass Diversified Holdings (CODI) | Q3 FY2025 | $472.6M | 3.5% | $-74.0M | -1.21 | — | 8-K |
| 2025-12-29 | DAILY JOURNAL CORP (DJCO) | Q4 FY2025 | $28.4M | 43.0% | $42.2M | 30.59 | — | 8-K |
| 2025-12-29reported in filing | NOBLE ROMANS INC (NROM) | Q3 FY2025 | $4.1M | 6.8% | $639,792 | 0.03 | 200.0% | 8-K |
| 2025-12-23 | Bridgeline Digital, Inc. (BLIN) | Q4 FY2025 | $3.9M | 0.2% | $-365,000 | -0.03 | — | 8-K |
| 2025-12-23 | Barnes & Noble Education, Inc. (BNED) | Q2 FY2026 | $598.2M | 6.9% | $25.0M | 0.72 | -55.8% | 8-K |
| 2025-12-23 | Good Times Restaurants Inc. (GTIM) | Q4 FY2025 | $34.0M | -4.9% | $-3,000 | -0.00 | -101.3% | 8-K |
| 2025-12-23 | Limoneira CO (LMNR) | Q4 FY2025 | $41.3M | -2.8% | $-8.7M | -0.49 | — | 8-K |
| 2025-12-22reported in filing | BNB PLUS CORP. (BNBX) | Q4 FY2025 | $199,429 | -59.1% | $-5.3M | — | — | 8-K |
| 2025-12-22 | ENNIS, INC. (EBF) | Q3 FY2026 | $100.2M | 0.4% | $10.8M | 0.42 | 7.7% | 8-K |
| 2025-12-22 | HONEYWELL INTERNATIONAL INC (HON) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2025-12-22reported in filing | Maison Solutions Inc. (MSS) | Q2 FY2026 | $27.6M | -5.9% | $-5.0M | -0.23 | — | 8-K |
| 2025-12-22reported in filing | Marwynn Holdings, Inc. (MWYN) | Q2 FY2026 | $43,750 | 0.0% | $-896,287 | -0.05 | — | 8-K |
| 2025-12-22 | SIFCO INDUSTRIES INC (SIF) | Q4 FY2025 | $22.8M | 5.3% | $-429,000 | -0.07 | — | 8-K |
| 2025-12-19 | BARNWELL INDUSTRIES INC (BRN) | Q4 FY2025 | $2.9M | -19.0% | $-2.4M | -0.24 | — | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.